- Public Comps
- BOC International China
BOC International China Valuation Multiples
Discover BOC International China's revenue and EBITDA valuation multiples and investment history, alongside public comparables like Guoyuan Securities, 360 One Wam, Webull, Moelis & Company and more.
BOC International China Overview
About BOC International China
BOC International China Co Ltd is engaged in Investment banking business, securities brokerage business, asset management business, securities proprietary business, private equity investment business, futures business, and other businesses. It generates the majority of its revenue from the Securities brokerage business.
Founded
2002
HQ

Employees
2.9K
Website
Financials (FY)
EV
$134M
Valuation Multiples
Start free trialBOC International China Financials
BOC International China reported last fiscal year revenue of $505M.
In the same fiscal year, BOC International China generated $156M in net income.
Revenue (LTM)
BOC International China P&L
In the most recent fiscal year, BOC International China reported revenue of $505M and net income of $156M.
BOC International China is profitable as of last fiscal year, with net margin of 31%.
Financial data powered by Morningstar, Inc.
BOC International China Stock Performance
BOC International China has current market cap of $5B, and enterprise value of $134M.
Market Cap Evolution
BOC International China's stock price is $1.79.
BOC International China share price decreased by 11.4% in the last year.
BOC International China has an EPS (earnings per share) of $0.06.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $134M | $5B | -0.6% | 0.0% | -4.1% | -11.4% | $0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBOC International China Valuation Multiples
BOC International China trades at 0.3x EV/Revenue multiple.
EV / Revenue (LTM)
BOC International China Financial Valuation Multiples
As of September 1, 2026, BOC International China has market cap of $5B and EV of $134M.
BOC International China has a P/E ratio of 29.5x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified BOC International China Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


BOC International China Margins & Growth Rates
In the most recent fiscal year, BOC International China reported net margin of 31%.
BOC International China Margins
BOC International China Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
BOC International China Operational KPIs
BOC International China's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Data powered by FactSet, Inc. and Morningstar, Inc.
BOC International China Competitors
BOC International China competitors include Guoyuan Securities, 360 One Wam, Webull, Moelis & Company, Argo Investments, China Great Wall Securities, General de Galerias, HASI, Hongta Securities and 3i Infrastructure.
Most BOC International China public comparables operate across Investment Banking, Investment Brokerage, Asset Management and PE & VC.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.4x | 2.9x | - | - | |||
| 17.6x | 16.4x | 22.1x | 33.8x | |||
| 7.3x | 5.8x | 77.5x | 28.5x | |||
| 3.5x | 3.1x | 15.4x | 14.4x | |||
| 24.3x | - | - | - | |||
| 4.2x | 5.2x | - | - | |||
| 18.8x | - | 18.1x | - | |||
| 25.9x | 23.3x | 37.8x | 71.0x | |||
This data is available for Pro users. Sign up to see all BOC International China competitors and their valuation data. Start Free Trial | ||||||
Investments by BOC International China
BOC International China has invested in 10 companies to date.
Latest investment by BOC International China was on August 2nd 2026. BOC International China invested in PaXini Tech in their $148M Series C round (EV/Revenue multiple available to Pro users).
Latest Investments by BOC International China
| Description | PaXini Tech is a Chinese manufacturer of tactile sensors for advanced applications. The company's flexible pressure-sensitive films enable touch feedback in robotic grippers, automotive interfaces, wearable health monitors, and virtual reality gloves. PaXini products support high-resolution sensing up to 100 Hz, used in humanoid robots and surgical simulators. Based in Shenzhen since 2018, the firm supplies components to automation firms across Asia. | Delova Biotech is a China- and US-focused developer of improved analgesics using proprietary preparation technologies. It enhances existing pain drugs and researches new formulations through R&D platforms. | - | Vivolight is a medical device manufacturer specializing in laser technology for minimally invasive interventional diagnosis and treatment. Headquartered in Shenzhen with an R&D center in Xi'an, it leverages photoelectric advancements combined with medical engineering. The company secured NMPA approval for its optical coherence tomography system in April 2020 and its Multimodality OCT System in December 2021, marking the first such approval for coronary artery applications. Multiple interventional laser therapy products advance through pre-clinical stages. Founded in 2012 and incubated by Xi'an Institute of Optics and Precision Mechanics. | |
| HQ Country | |||||
| HQ City | Shenzhen | Yantai | - | Shenzhen | |
| Deal Date | 2 Aug 2026 | 21 Jul 2026 | 2 Jul 2026 | 31 May 2026 | |
| Round | Series C | Series C | Undisclosed stage | Series E | |
| Raised | $148M | $88M | undisclosed | undisclosed | |
| Investors | BOC International China; Zhilaibank Capital; Jinrong Guosheng; Jingming Capital; Chengdu Jiazi Artificial Intelligence Fund; Kunpeng Fund; CDH Investments; Hexin Fangce | Peakview Capital; BOC International China; RiverHead Capital; Guangzhou Guoju Venture Capital; Caixin Industry Fund; EFung Capital; Guosen H&S Investments; Tailong Investment; Nanjing Innovation Capital Group; Guangdong Traditional Chinese Medicine Health Fund; Oriza Holdings; Jiangsu High Investment; Guangzhou Industrial Investment Group | Jiuzhi Ziben; BOC International China; Hua Capital; Fuzhou State-owned Assets Investment Holding; Angel Plus China; CMB International Capital Corporation; Hangzhou Capital; Holox World; Yuanhe Capital; Junli Capital | BOC International China; Sino-US Green Yangtze River Delta Investment Fund; EFung Capital; Huiyu Investment | |
| Valuation | undisclosed | undisclosed | undisclosed | undisclosed | |
| EV/Revenue | |||||
| EV/EBITDA | |||||
This data is available for Pro users. Sign up to see all BOC International China investments and their VC round multiples. Start Free Trial | |||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout BOC International China
| When was BOC International China founded? | BOC International China was founded in 2002. |
| Where is BOC International China headquartered? | BOC International China is headquartered in China. |
| How many employees does BOC International China have? | As of today, BOC International China has over 2K employees. |
| Who is the CEO of BOC International China? | BOC International China's CEO is Bing Zhou. |
| Is BOC International China publicly listed? | Yes, BOC International China is a public company listed on Shanghai Stock Exchange. |
| What is the stock symbol of BOC International China? | BOC International China trades under 601696 ticker. |
| When did BOC International China go public? | BOC International China went public in 2020. |
| Who are competitors of BOC International China? | BOC International China main competitors include Guoyuan Securities, 360 One Wam, Webull, Moelis & Company, Argo Investments, China Great Wall Securities, General de Galerias, HASI, Hongta Securities, 3i Infrastructure. |
| What is the current market cap of BOC International China? | BOC International China's current market cap is $5B. |
| What is the current revenue of BOC International China? | BOC International China's last fiscal year revenue is $505M. |
| What is the current EV/Revenue multiple of BOC International China? | Current revenue multiple of BOC International China is 0.3x. |
| What is the current net income of BOC International China? | BOC International China's last 12 months net income is $168M. |
| How many companies BOC International China has acquired to date? | BOC International China hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies BOC International China has invested to date? | As of September 2026, BOC International China has invested in 10 companies. |
| What was the last BOC International China investment? | On 2nd August 2026 BOC International China invested in PaXini Tech, participating in a $148M Series C round, alongside Zhilaibank Capital, Jinrong Guosheng, Jingming Capital, Chengdu Jiazi Artificial Intelligence Fund, Kunpeng Fund, CDH Investments, and Hexin Fangce. |
| In what companies BOC International China invested in? | BOC International China invested in Miaoshou Doctor, Sunwoda Electric Vehicle Battery, SemiDrive, PaXini Tech, Delova Biotech, Sinsegye, Smart Satellite Technology, Yaspeed, Vivolight, and Bose Quantum. |
See public comps similar to BOC International China
Lists including BOC International China
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.





